Device
Normothermic Machine Perfusion (NMP)
Normothermic Machine Perfusion (NMP) is a medical device with 4 clinical trials. Historical success rate of 33.3%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
33.3%
Based on 1 completed trials
Completion Rate
33%(1/3)
Active Trials
0(0%)
Results Posted
200%(2 trials)
Terminated
2(50%)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(1)
Terminated(2)
Other(1)
Detailed Status
Terminated2
unknown1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
33.3%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
unknown125%
completed125%
terminated250%
Recent Activity
0 active trials
Showing 4 of 4
terminatednot_applicable
WP02 Continued Access Study
NCT04862156
terminatednot_applicable
Efficacy of Ex-situ Normothermic Perfusion Versus Cold Storage in the Transplant With Steatotic Liver Graft.
NCT03930459
completednot_applicable
WP01 - Normothermic Liver Preservation
NCT02775162
unknownnot_applicable
Hypothermic Oxygenated (HOPE) Versus Normothermic Machine Perfusion (NMP) in Human Liver Transplantation
NCT04644744
Clinical Trials (4)
Showing 4 of 4 trials
NCT04862156Not Applicable
WP02 Continued Access Study
NCT03930459Not Applicable
Efficacy of Ex-situ Normothermic Perfusion Versus Cold Storage in the Transplant With Steatotic Liver Graft.
NCT02775162Not Applicable
WP01 - Normothermic Liver Preservation
NCT04644744Not Applicable
Hypothermic Oxygenated (HOPE) Versus Normothermic Machine Perfusion (NMP) in Human Liver Transplantation
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4